Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788128 | SCV000927137 | uncertain significance | not provided | 2017-01-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001296888 | SCV001485865 | uncertain significance | DOCK2 deficiency | 2020-07-24 | criteria provided, single submitter | clinical testing | Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change falls in intron 22 of the DOCK2 gene. It does not directly change the encoded amino acid sequence of the DOCK2 protein, but it affects a nucleotide within the consensus splice site of the intron. This variant is present in population databases (rs774041924, ExAC 0.03%). This variant has not been reported in the literature in individuals with DOCK2-related conditions. ClinVar contains an entry for this variant (Variation ID: 636342). |